Cargando…
Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case Report
DNA mismatch repair deficient (dMMR) and microsatellite instable (MSI) metastatic colorectal cancer (mCRC) can be successfully treated with FDA- and EMA-approved immune checkpoint inhibitors (ICI) pembrolizumab and nivolumab (as single agents targeting the anti-programmed cell death protein-1 (PD-1)...
Autores principales: | Krekeler, Carolin, Wethmar, Klaus, Mikesch, Jan-Henrik, Kerkhoff, Andrea, Menck, Kerstin, Lenz, Georg, Schildhaus, Hans-Ulrich, Wessolly, Michael, Hoffmann, Matthias W., Pascher, Andreas, Asmus, Inga, Wardelmann, Eva, Bleckmann, Annalen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418401/ https://www.ncbi.nlm.nih.gov/pubmed/37569431 http://dx.doi.org/10.3390/ijms241512056 |
Ejemplares similares
-
Liquid Biopsies in Lung Cancer
por: Kemper, Marcel, et al.
Publicado: (2023) -
Microvesicles in Cancer: Small Size, Large Potential
por: Menck, Kerstin, et al.
Publicado: (2020) -
The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention
por: Menck, Kerstin, et al.
Publicado: (2021) -
Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World Scenario
por: Krekeler, Carolin, et al.
Publicado: (2022) -
Isolation and Characterization of Microvesicles from Peripheral Blood
por: Menck, Kerstin, et al.
Publicado: (2017)